- Olopatadine 1mg/ml eye drops
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Olopatadine 1mg/ml eye drops | Start Date 21-02-2012 | End Date |
Previous Name | Previous Name Olopatadine 0.1% eye drops | Start Date 17-06-2003 |
End Date
|
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Ocular
- Form
- Eye drops
- Ontology Form/Route
- solutiondrops.ophthalmic
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- S01GX09
BNF | Start Date | End Date |
---|---|---|
Current BNF 11040200 | Start Date 04-04-2022 | End Date |
Previous BNF 11040200 | Start Date 16-02-2005 | End Date 03-04-2022 |
Code | Start Date | End Date |
---|---|---|
42193511000001105 | 25-08-2023 | |
408020000 | 17-08-2005 | 24-08-2023 |
4600911000001103 | 17-06-2003 | 16-08-2005 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Olopatadine hydrochloride | Based on Base Substance | Olopatadine | 1 mg | 1 ml |
Name
Olopatadine hydrochloride
Basis of strength description
Based on Base Substance
BOSS
Olopatadine
Strength and UOM (Nmr)
1
Strength and UOM (Dmr)
1
Parent Products
-
VTMOlopatadine
-
VMP(Current) Olopatadine 1mg/ml eye drops
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
5 ml | 564 | Part VIIIA Category A |